Marc Frahm – TD Cowen

TD Cowen

A TD Cowen analyst with 6 tracked ratings across 6 distinct tickers has a 4.8-star track record, exclusively issuing bullish ratings on the captured sample.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

3 days ago

2026-06-01 00:00:00+00

Track record

Aggregated

No track record data

Bullish: 14
Hold: 0
Bearish: 0

Aggregated

50% success rate

Bullish: 0
Hold: 1
Bearish: 0

Aggregated

Not available

Bullish: 3
Hold: 4
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
CRDF	2026-06-01	hold	-	Aggregated
RVMD	2026-06-01	buy	-	Aggregated
CRDF	2026-05-14	buy	-	Aggregated
SANA	2026-05-11	buy	$2027.00	Aggregated
JANX	2026-05-08	buy	-	Aggregated
NKTR	2026-05-08	buy	-	Aggregated
GLUE	2026-05-07	buy	-	Aggregated
NUVL	2026-05-07	buy	-	Aggregated
SRRK	2026-05-07	buy	-	Aggregated
RVMD	2026-05-06	buy	$151.07	Aggregated
AGIO	2026-04-29	buy	-	Aggregated
TBPH	2026-03-23	hold	$15.00	Aggregated
NKTR	2026-03-17	buy	-	Aggregated
INCY	2026-01-13	buy	$128.00	Aggregated
XLO	2025-11-13	buy	-	Aggregated
SANA	2025-01-08	buy	-	Aggregated
TBPH	2024-08-06	hold	$9.00	Aggregated
TBPHTHERAVANCE BIOPHARMA INC	2024-08-06	hold	$9.00	Aggregated
INCYINCYTE CORP.	2024-05-01	unknown	$80.00	Aggregated
SANA	2023-08-14	hold	-	Aggregated

Tickers covered(14)

Ticker	Ratings	Last rating	Sources
CRDF	2	2026-06-01	Aggregated
RVMD	2	2026-06-01	Aggregated
SANA	4	2026-05-11	Aggregated
JANX	1	2026-05-08	Aggregated
NKTR	2	2026-05-08	Aggregated
GLUE	2	2026-05-07	Aggregated
NUVL	1	2026-05-07	Aggregated
SRRK	1	2026-05-07	Aggregated
AGIO	1	2026-04-29	Aggregated
TBPH	2	2026-03-23	Aggregated
INCY	1	2026-01-13	Aggregated
XLO	2	2025-11-13	Aggregated
TBPHTHERAVANCE BIOPHARMA INC	1	2024-08-06	Aggregated
INCYINCYTE CORP.	1	2024-05-01	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.